79 related articles for article (PubMed ID: 28039441)
1. MUC1-C drives DNA methylation in cancer.
Rajabi H; Tagde A; Kufe D
Aging (Albany NY); 2016 Dec; 8(12):3155-3156. PubMed ID: 28039441
[No Abstract] [Full Text] [Related]
2. Oncogenic function of the MUC1 receptor subunit in gene regulation.
Kufe D
Oncogene; 2010 Oct; 29(42):5663-6. PubMed ID: 20711235
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.
Rajabi H; Hata T; Li W; Long MD; Hu Q; Liu S; Raina D; Kui L; Yasumizu Y; Hong D; Samur M; Kufe D
Oncogene; 2019 Nov; 38(47):7266-7277. PubMed ID: 31435022
[TBL] [Abstract][Full Text] [Related]
4. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
[TBL] [Abstract][Full Text] [Related]
5. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.
Kufe DW
Carcinogenesis; 2020 Sep; 41(9):1173-1183. PubMed ID: 32710608
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
8. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.
Yonezawa S; Goto M; Yamada N; Higashi M; Nomoto M
Proteomics; 2008 Aug; 8(16):3329-41. PubMed ID: 18651706
[TBL] [Abstract][Full Text] [Related]
10. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
11. Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters.
Kitahashi T; Takahashi M; Imai T
Pancreas; 2015 Jan; 44(1):76-86. PubMed ID: 25036908
[TBL] [Abstract][Full Text] [Related]
12. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
[TBL] [Abstract][Full Text] [Related]
13. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW
Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028
[TBL] [Abstract][Full Text] [Related]
14. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
15. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis.
Hanson RL; Brown RB; Steele MM; Grandgenett PM; Grunkemeyer JA; Hollingsworth MA
Oncotarget; 2016 Jun; 7(26):39996-40011. PubMed ID: 27220889
[TBL] [Abstract][Full Text] [Related]
16. [DNA methylation: an epigenetic mechanism for tumorigenesis].
Zhang LL; Wu JX
Yi Chuan; 2006 Jul; 28(7):880-5. PubMed ID: 16825178
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation changes in cancer.
Toyota M; Yamamoto E
Prog Mol Biol Transl Sci; 2011; 101():447-57. PubMed ID: 21507361
[TBL] [Abstract][Full Text] [Related]
18. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
Arai E; Kanai Y
Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications and human pathologies: cancer and CVD.
Duthie SJ
Proc Nutr Soc; 2011 Feb; 70(1):47-56. PubMed ID: 21067630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
